跳至主要内容
临床试验/DRKS00030884
DRKS00030884招募中3 期

The effect of targeted high intensity interval training (HIIT) during cardiotoxic cancer treatment on cardiovascular health – a pilot study - ENTRANCE

niklinik Köln0 个研究点目标入组 20 人开始时间: 2022年12月12日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • Patients (= 18 years) with initial diagnosis of cancer (breast cancer).
  • - Indication for anthracycline therapy
  • - Prior to initiation of medical therapy (max. 2 weeks after diagnosis).
  • - Life expectancy =18 months
  • - Written and valid informed consent from the patient.

排除标准

  • - Contraindications to exercise therapy interventions and all disease situations that do not allow exercise, in particular:
  • - previous myocardial infarction or CABG
  • - angina pectoris
  • - EF < 50%
  • - previous cardiotoxicity / or previous potential cardiotoxic therapy
  • - Age > 80 years
  • - BMI > 30 or > 150 kg body weight

研究者

发起方
niklinik Köln

相似试验